Group One Trading, L.P. Seelos Therapeutics, Inc. Transaction History

Group One Trading, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.16 - $1.64 $4,810 - $49,306	-30,065 Reduced 9.62%	282,327 $50,000
Q2 2023 Aug 09, 2023	SELL	$0.66 - $1.22 $7,216 - $13,339	-10,934 Reduced 3.38%	312,392 $374,000
Q1 2023 May 12, 2023	SELL	$0.59 - $1.04 $568,679 - $1 Million	-963,863 Reduced 74.88%	323,326 $223,000
Q4 2022 Feb 09, 2023	SELL	$0.66 - $259.46 $577,352 - $227 Million	-874,776 Reduced 40.46%	1,287,189 $875,000
Q3 2022 Nov 09, 2022	SELL	$0.65 - $278.68 $103,337 - $44.3 Million	-158,981 Reduced 6.85%	2,161,965 $2.23 Million
Q2 2022 Aug 11, 2022	BUY	$0.51 - $0.93 $40,737 - $74,286	79,878 Added 3.56%	2,320,946 $1.58 Million
Q1 2022 May 12, 2022	BUY	$0.84 - $1.71 $1.07 Million - $2.17 Million	1,271,075 Added 131.04%	2,241,068 $1.88 Million
Q4 2021 Feb 11, 2022	BUY	$1.59 - $2.38 $1.54 Million - $2.31 Million	969,993 New	969,993 $1.58 Million
Q3 2021 Nov 12, 2021	SELL	$1.69 - $2.89 $48,143 - $82,327	-28,487 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$2.64 - $6.32 $75,205 - $180,037	28,487 New	28,487 $75,000
Q1 2021 May 12, 2021	SELL	$1.35 - $4.99 $22 - $84	-17 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.45 - $8.1 $24 - $137	17 New	17 $0

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.